Bandingkan Harga & Kinerja DFI Retail Nusantara Tbk. (HERO) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan DFI Retail Nusantara Tbk. dan Organon Pharma Indonesia Tbk.: DFI Retail Nusantara Tbk. diperdagangkan di Rp334 (kapitalisasi pasar 1,41 T, volume 24 jam 46,7 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: DFI Retail Nusantara Tbk. jauh lebih besar — sekitar 13,5× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| HERO | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 1,41 T | 104,4 M |
Volume | 46,7 rb | — |
Lot | 467 | — |
Perputaran | 15,36 jt | — |
Harga Rata-rata | 328,81 | — |
Nilai Transaksi | 15,36 jt | — |
Harga Ekuilibrium Indikatif | 340 | — |
Volume Ekuilibrium Indikatif | 7 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang DFI Retail Nusantara Tbk.
The company began its commercial operations in August 1972. Hero is Indonesia’s largest supermarket chain with a network of 66 supermarkets, consisting of 44 stores in Greater Jakarta and 22 stores in major regional cities. Supermarket operations account for about 90% of sales complemented by an array of retail formats including convenience stores, mini markets, and pharmacies. The company’s mission is to be the leading modern food retailer in Indonesia in terms of sales and profits, targeting the middle to upper income consumer segments where buying power is greatest. As the economy begins to gather strength, HERO has relatively aggressive expansion plans drawing upon its established brand, a reputation for fresh quality foods, friendly experienced staff, best service, a leading position in category and space management and efficient centralized distribution infrastructure. In 1998 the acquisition of a 32% effective interest in Hero by Dairy Farm International contributed significant international experience and expertise to the local knowledge and insight of Hero’s management as well as recognition of the potential of Indonesia as one of the most attractive growth markets in South East Asia over the medium long term.
Selengkapnya di halaman HERO →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
